Therapies
The Science
About us
Investors
News

Hit enter to search or ESC to close

Prana – ANA Abstract Submission NLP

October 17, 2016 Kerry Rowe

final-ana-abstract-submission-nlp-4-8-16

Post navigation

New data from Reach2HD trial presented at American Neurological Association Annual Meeting

Related Posts

Prana to Present at the B. Riley FBR China Healthcare Investment & Partnering Symposium in Hangzhou, China

March 15, 2018

Prana Maintains NASDAQ Listing

April 11, 2016

New data from Reach2HD trial presented at American Neurological Association Annual Meeting

October 18, 2016

Recent Posts

Chairman’s Address to Shareholders 2019 Annual General Meeting
AGM 2019 Presentation
Alterity AGM Investor Conference Call
Alterity’s lead drug candidate receives positive opinion from European medical agency
Quarterly Cash Flow Report

Recent Comments

Archives

Archives

Categories

ASX Announcements
Investor Announcement

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Therapies
The Science
About us
Investors
News
Contact us

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065